A0828512
Atovaquone , ≥98% , 95233-18-4
Synonym(s):
Atovaquone;Mepron;trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
| Pack Size | Price | Stock | Quantity |
| 250MG | RMB159.20 | In Stock |
|
| 1G | RMB319.20 | In Stock |
|
| 5g | RMB1039.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 216-2190C |
| Boiling point: | 535.0±50.0 °C(Predicted) |
| Density | 1.349±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: >10mg/mL |
| pka | 5.01±0.10(Predicted) |
| form | powder |
| color | yellow |
| λmax | 494nm(aq. Buffer)(lit.) |
| Merck | 14,866 |
| InChIKey | KUCQYCKVKVOKAY-CTYIDZIISA-N |
Description and Uses
Atovaquone is an orally active antiprotozoal agent indicated for patients with mild to moderate AIDS-associated Pneumocystis carinii pneumonia who are intolerant to the fist-line therapy of trimethoprim-sulfamethoxazole. It is also under investigation as a treatment for malaria and AIDS-associated toxoplasmosis.
beta-adrenergic blocker
